SUVRETTA CAPITAL MANAGEMENT, LLC - Q3 2021 holdings

$5.94 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 106 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 68.4% .

 Value Shares↓ Weighting
UNH BuyUNITEDHEALTH GROUP INC$279,423,000
+0.9%
715,113
+3.4%
4.71%
+13.6%
MA BuyMASTERCARD INCORPORATEDcl a$234,475,000
+17.9%
674,400
+23.8%
3.95%
+32.8%
RH BuyRH$223,382,000
+8.2%
334,951
+10.1%
3.76%
+21.9%
OTIS BuyOTIS WORLDWIDE CORP$222,118,000
+3.5%
2,699,539
+2.8%
3.74%
+16.5%
TPR BuyTAPESTRY INC$199,095,000
-11.6%
5,378,032
+3.8%
3.35%
-0.4%
OPEN BuyOPENDOOR TECHNOLOGIES INC$193,944,000
+63.2%
9,446,879
+40.9%
3.27%
+83.8%
TMO NewTHERMO FISHER SCIENTIFIC INC$186,145,000325,810
+100.0%
3.14%
IQV BuyIQVIA HLDGS INC$168,441,000
+16.9%
703,187
+18.2%
2.84%
+31.6%
TWLO BuyTWILIO INCcl a$164,796,000
+33.2%
516,520
+64.5%
2.78%
+50.0%
PWR BuyQUANTA SVCS INC$158,077,000
+37.2%
1,388,834
+9.2%
2.66%
+54.6%
ABC BuyAMERISOURCEBERGEN CORP$147,502,000
+9.7%
1,234,845
+5.1%
2.48%
+23.6%
PLAN BuyANAPLAN INC$131,841,000
+23.3%
2,165,238
+8.0%
2.22%
+38.9%
CPRT BuyCOPART INC$121,070,000
+10.9%
872,764
+5.4%
2.04%
+24.9%
CANO BuyCANO HEALTH INC$106,753,000
+23.2%
8,419,011
+17.6%
1.80%
+38.8%
PTON BuyPELOTON INTERACTIVE INC$101,570,000
+11.7%
1,166,800
+59.1%
1.71%
+25.8%
ALIT NewALIGHT INC$95,858,0008,350,000
+100.0%
1.62%
NTRA BuyNATERA INC$83,270,000
+107.4%
747,220
+111.3%
1.40%
+133.4%
ADI BuyANALOG DEVICES INC$79,996,000
+49.1%
477,645
+53.3%
1.35%
+68.1%
HWM BuyHOWMET AEROSPACE INC$79,598,000
+39.0%
2,551,230
+53.6%
1.34%
+56.7%
SQ NewSQUARE INCcl a$72,655,000302,930
+100.0%
1.22%
AGIO BuyAGIOS PHARMACEUTICALS INC$60,537,000
+11.2%
1,311,748
+32.8%
1.02%
+25.3%
MA NewMASTERCARD INCORPORATEDcall$60,010,000172,600
+100.0%
1.01%
RPRX BuyROYALTY PHARMA PLC$55,218,000
+84.7%
1,527,900
+109.5%
0.93%
+108.1%
FULC BuyFULCRUM THERAPEUTICS INC$54,783,000
+221.2%
1,941,969
+19.3%
0.92%
+262.0%
NewWARBY PARKER INC$53,050,0001,000,000
+100.0%
0.89%
ITCI BuyINTRA-CELLULAR THERAPIES INC$46,673,000
+10.1%
1,251,946
+20.5%
0.79%
+24.0%
KURA BuyKURA ONCOLOGY INC$46,080,000
+33.2%
2,460,202
+48.3%
0.78%
+50.1%
STRO BuySUTRO BIOPHARMA INC$42,194,000
+32.3%
2,233,695
+30.2%
0.71%
+49.1%
ESTC NewELASTIC N V$40,376,000271,000
+100.0%
0.68%
MRTX BuyMIRATI THERAPEUTICS INC$33,844,000
+40.7%
191,308
+28.5%
0.57%
+58.3%
ARNA NewARENA PHARMACEUTICALS INC$30,197,000507,088
+100.0%
0.51%
DCPH BuyDECIPHERA PHARMACEUTICALS IN$29,295,000
+22.6%
862,126
+32.1%
0.49%
+38.4%
INSM BuyINSMED INC$27,505,000
+119.1%
998,732
+126.4%
0.46%
+146.3%
KALV BuyKALVISTA PHARMACEUTICALS INC$26,930,000
-5.6%
1,543,284
+29.6%
0.45%
+6.3%
BuyMARINUS PHARMACEUTICALS INC$25,007,000
-23.7%
2,197,426
+20.3%
0.42%
-14.1%
MREO BuyMEREO BIOPHARMA GROUP PLCads$22,124,000
-19.3%
9,142,067
+5.7%
0.37%
-9.0%
FREY NewFREYR BATTERY$20,665,0002,093,710
+100.0%
0.35%
EYPT BuyEYEPOINT PHARMACEUTICALS INC$17,762,000
+43.3%
1,704,589
+23.7%
0.30%
+61.6%
XENE BuyXENON PHARMACEUTICALS INC$17,709,000
+60.1%
1,158,961
+95.1%
0.30%
+80.6%
AGLE BuyAEGLEA BIOTHERAPEUTICS INC$17,154,000
+17.7%
2,157,727
+3.0%
0.29%
+32.6%
PNT NewPOINT BIOPHARMA GLOBAL INC$17,110,0002,225,000
+100.0%
0.29%
BOLT BuyBOLT BIOTHERAPEUTICS INC$16,768,000
+13.7%
1,325,500
+38.9%
0.28%
+28.1%
NewDICE THERAPEUTICS INC$13,428,000410,000
+100.0%
0.23%
KDNY BuyCHINOOK THERAPEUTICS INC$13,366,000
-2.2%
1,047,468
+8.2%
0.22%
+10.3%
NewROCKET LAB USA INC$12,098,000750,000
+100.0%
0.20%
CMRX BuyCHIMERIX INC$11,808,000
+78.9%
1,907,620
+131.2%
0.20%
+101.0%
NewCAZOO GROUP LTD$11,730,0001,509,700
+100.0%
0.20%
TERN BuyTERNS PHARMACEUTICALS INC$11,730,000
-15.0%
1,125,736
+0.1%
0.20%
-3.9%
INZY BuyINOZYME PHARMA INC$11,432,000
+83.7%
986,400
+170.1%
0.19%
+107.5%
BCAB NewBIOATLA INC$10,427,000354,190
+100.0%
0.18%
GMTX BuyGEMINI THERAPEUTICS INC$8,637,000
-37.5%
2,137,823
+0.1%
0.15%
-29.5%
NewEVOLV TECHNOLOGIES HLDNGS IN$8,207,0001,367,870
+100.0%
0.14%
CHRS NewCOHERUS BIOSCIENCES INC$7,864,000489,333
+100.0%
0.13%
NewNERDY INC$6,993,000700,000
+100.0%
0.12%
NewARCHER AVIATION INC$6,660,000750,000
+100.0%
0.11%
ACIU NewAC IMMUNE SA$6,465,000963,500
+100.0%
0.11%
NewFRESHWORKS INC$6,404,000150,000
+100.0%
0.11%
NewIMMUNEERING CORP$5,310,000200,000
+100.0%
0.09%
MAAC NewMONTES ARCHIMEDES ACQUISITIO$4,675,000500,000
+100.0%
0.08%
NewNUVALENT INC$4,510,000200,000
+100.0%
0.08%
ORIC NewORIC PHARMACEUTICALS INC$3,118,000149,100
+100.0%
0.05%
NewVOLTA INC$2,595,000300,000
+100.0%
0.04%
ALITWS NewALIGHT INC*w exp 05/26/202$2,362,000774,375
+100.0%
0.04%
SYBX NewSYNLOGIC INC$183,00060,000
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2021-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADOBE SYSTEMS INCORPORATED33Q4 202113.2%
CONSTELLATION BRANDS INC20Q4 201810.9%
AMAZON COM INC20Q3 20238.0%
UNITEDHEALTH GROUP INC20Q3 20235.7%
IQVIA HLDGS INC19Q3 20237.3%
RESTAURANT BRANDS INTL INC18Q3 20198.9%
UNION PAC CORP17Q2 20235.1%
META PLATFORMS INC16Q3 202310.9%
COPART INC15Q4 20212.3%
SUTRO BIOPHARMA INC15Q3 20231.9%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SUVRETTA CAPITAL MANAGEMENT, LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Zura Bio LtdJune 15, 20232,850,0006.6%
InflaRx N.V.April 24, 20235,733,91010.3%
Benitec Biopharma Inc.April 18, 20233,020,21410.0%
Aeglea BioTherapeutics, Inc.February 13, 20236,376,37310.0%
Bolt Biotherapeutics, Inc.Sold outFebruary 13, 202300.0%
Cano Health, Inc.Sold outFebruary 13, 202300.0%
CHIMERIX INCSold outFebruary 13, 202300.0%
Disc Medicine, Inc.Sold outFebruary 13, 202300.0%
OTONOMY, INC.Sold outFebruary 13, 202300.0%
Sio Gene Therapies Inc.Sold outFebruary 13, 202300.0%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
32024-05-02
SC 13D2024-04-29
SC 13G2024-04-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export SUVRETTA CAPITAL MANAGEMENT, LLC's holdings